Literature DB >> 1702246

Detection of foot-and-mouth disease virus by competitive ELISA using a monoclonal antibody specific for the 12S protein subunit from six of the seven serotypes.

E N Smitsaart1, J C Saiz, R J Yedloutschnig, D O Morgan.   

Abstract

Foot-and-mouth disease (FMD) prevention and control programs are dependent upon rapid, reliable diagnostic procedures. The widely used FMD diagnostic complement fixation (CF) procedures require a specific antiserum for each of the seven FMDV serotypes making the tests both cumbersome and difficult to standardize. An FMD diagnostic, monoclonal antibody based inhibition-ELISA procedure was developed. The test uses a single monoclonal antibody (MAb) that reacts with all European and South American FMDV isolates examined. The procedure detects a highly conserved epitope on the 12S protein subunit of FMDV which appears to be common to all FMDV's with the exception of the South African Territories 2 serotype. The results indicate that the sensitivity of this test is greater than CF and approaches that of virus isolation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702246     DOI: 10.1016/0165-2427(90)90095-a

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  3 in total

Review 1.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

2.  Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs.

Authors:  S A Lewis; D O Morgan; M J Grubman
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine.

Authors:  A Rodríguez; J Dopazo; J C Sáiz; F Sobrino
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.